Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewThe Biotech Act will be divided into two phases: the first, focused on health, is expected...
It will take the form of an omnibus law, bringing together multiple provisions on health, clinical trials, in vitro diagnostics, medical devices, food, and feed. The second phase, focused on
-
-
NewGENESIS Biomed, sponsor of BIOSPAIN 2025, has been involved in the event with active parti...
BIOSPAIN, the largest biotechnology event organised by a national bioindustry association in Europe, closed its 12th edition in Barcelona on October 9 after three days of events with AseBio as
-
-
NewBiotechnology: a key ally in the fight against breast cancer
According to the AECC, around 35,875 new cases were diagnosed in 2024, accounting for nearly 29% of all tumors detected in women.
-
Press releaseBiotechnology: a key ally in the fight against breast cancer
Biotechnological innovation is transforming treatments toward safer, more effective and personalized options. Nanotechnology-based therapies mark a new era in oncology treatment. According to the AECC
-
EventHealth Tech Forward 2025
-
NewBiotechnology and Alternative Proteins: The Recipe for a Sustainable Food System
On World Food Day 2025, biotechnology emerges as a driving force for building more sustainable, inclusive, and future-ready food systems.
-
Press releaseBiotechnology: A key ally in the challenge of feeding 10 billion people
Biotechnology drives solutions to optimize the use of natural resources, reduce emissions, and advance toward a circular economy. The development of alternative proteins — plant-based, microbial, or
-
New#AseBioGallery | This was BIOSPAIN 2025
The International Biotechnology Meeting BIOSPAIN 2025 was held from October 7 to 9 at the Fira de Barcelona – Montjuïc.
-
New#NewAseBioMember | “It is much more than an industry association; it is the meeting point ...
Meet Fundación para la Investigación de Sanitas Hospitales, our new member. We spoke with José Francisco Tomás, president of FISH.
-
New#NewAseBioMember | "AseBio represents a strategic community that drives biotechnology forw...
Meet Succipro, our new member. We spoke with Isabel Huber Ruano, CEO
-
EventBioLatam Digital 2025
-
EventBIOSPAIN 2026
The 13th edition of BIOSPAIN will be held in Bilbao from September 29 to October 1, 2026.
-
NewBIOSPAIN 2025 closes with record attendance and passes the baton to Bilbao as 2026 host ci...
The edition closes with more than 2,400 attendees from over 1,000 organizations across 34 countries. BIOSPAIN 2025 brought together 140 investors representing 76 national and international investment
-
Press releaseBIOSPAIN 2025 closes with record attendance and passes the baton to Bilbao as 2026 host ci...
The edition closes with more than 2,400 attendees from over 1,000 organizations across 34 countries. BIOSPAIN 2025 brought together 140 investors representing 76 national and international investment
-
NewThe union of synthetic biology, artificial intelligence, and automation drives new biofuel...
Artificial intelligence enables the analysis of millions of biological data points to identify optimal solutions, while automation facilitates the transfer of results from the lab to industry.
-
Press releaseThe union of synthetic biology, artificial intelligence, and automation drives new biofuel...
Artificial intelligence enables the analysis of millions of biological data points to identify optimal solutions, while automation facilitates the transfer of results from the lab to industry
-
NewInvesting in Biotechnology: A Commitment to Excellence and the Real Impact of Innovation o...
The Spanish biotech ecosystem, despite its progress in investment, R&D, business creation, and international visibility, still needs to strengthen public-private collaborations and take greater
-
Press releaseInvesting in Biotechnology: A Commitment to Excellence and the Real Impact of Innovation o...
Experts advocate for the convergence of biotechnology, engineering, and digitalization as a driving force for industrial transformation, while emphasizing the need for multidisciplinary talent and
-
NewAdvanced therapies: a strategic pillar for European autonomy in biotechnology and health
The upcoming Biotech Act and the European Pharmaceutical Strategy are crucial for the development of advanced therapies in Europe, as they aim to create a more agile and predictable regulatory